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Abstract 1 
Child undernutrition is a major adverse public health burden in developing countries, 2 
specifically in sub-Saharan Africa and South Asia. Nutrition interventions such as 3 
micronutrient supplementation, as well as complementary feeding targeting the major 4 
micronutrient deficiencies have only reduced the burden of child undernutrition to a certain 5 
extent, indicating that others factors may play a role. Aflatoxin exposure, which is also highly 6 
prevalent in developing countries, may be considered to be an aggravating factor for child 7 
undernutrition. Increasing evidence suggests that aflatoxin exposure can occur in any stage of 8 
life including in utero through a trans-placental pathway and in early childhood (through 9 
contaminated weaning food and family food). Early life exposure to aflatoxin is associated with 10 
adverse effects on low birth weight, stunting, immune function suppression, and liver function 11 
damage. The mechanisms underlying impaired growth and aflatoxin exposure are still unclear 12 
but intestinal function damage, reduced immune function and alteration in the insulin-like 13 
growth factor axis caused by liver damage, are suggested hypotheses. Given the fact that both 14 
aflatoxin and child undernutrition are common in sub-Saharan Africa, effective interventions 15 
aimed at reducing undernutrition cannot be satisfactorily achieved until the interactive 16 
relationship between aflatoxin and child undernutrition is clearly understood and an aflatoxin 17 
mitigation strategy has taken effect in those vulnerable mothers and young children.   18 
 19 
Keywords: Aflatoxin, child undernutrition, stunting, kwashiorkor, micronutrient deficiencies 20 
 21 
Introduction  22 
Child undernutrition including stunting, wasting and micronutrient deficiencies is a major 23 
public health problem for low-income countries. The short- and long-term health consequences 24 
of child undernutrition can be severe and irreversible and include impaired cognitive 25 
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development, increased vulnerability to infectious diseases, and reduced educational outcomes 26 
and economic productivity in adulthood (1). Furthermore, undernutrition is responsible for 27 
approximately 3.1 million child deaths each year, with 45% of all child deaths in 2011 having 28 
been attributed to this cause (1).  29 
 30 
It is recognised that there is a window of opportunity for reducing the burden and the lasting 31 
impact of child undernutrition, in particular impaired growth. This critical period is defined as 32 
the first 1000 days of life from conception to 24 months of age (2, 3). Bhutta et al., (4) reviewed 33 
the potential effect on child undernutrition outcomes of interventions such as breastfeeding 34 
promotion, micronutrient supplementation and diversified complementary feeding during this 35 
critical period and up to 36 months in the 36 counties with the highest burden of child stunting. 36 
By modeling the survival and linear growth status of the annual birth cohort from birth to 36 37 
months, these authors concluded that existing interventions could potentially reduce stunting at 38 
36 months by 36%; mortality by 25% (from birth to 36 months); and stunting, wasting, fetal 39 
growth restriction and micronutrient deficiencies disability-adjusted life-years by 40 
approximately 25%. Although, these outcomes are encouraging, there are likely to be other 41 
underlying determinants of undernutrition that need to be addressed.  42 
 43 
There is increasing evidence that exposure to aflatoxin could be one of the underlying factors. 44 
Aflatoxin is a mycotoxin produced by Aspergillus flavus and Aspergillus parasiticus that 45 
contaminate staple crops in many of the countries where child stunting is also prevalent. 46 
Although Aspergillus molds occur in soil across a wide geographic distribution, hot and humid 47 
conditions are favourable for aflatoxin production, with stress to crops caused by drought 48 
conditions promoting the contamination of susceptible crops (such as maize and groundnuts) 49 
in the field (5). Further growth of the fungus and production of aflatoxin is enhanced by post-50 
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harvest storage conditions that involve high humidity (6). There are four main types of 51 
aflatoxin, namely aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1) and 52 
aflatoxin G2 (AFG2). AFB1 is the most potent toxin and is the most prevalent, accounting for 53 
an average of 70% of the total aflatoxin content in food, although this may vary depending on 54 
the strain of the fungus and local conditions. Aflatoxin M1 (AFM1) is a toxic metabolite of 55 
aflatoxin B1, which can be found in milk of lactating mothers, and milk and meat of animals 56 
exposed to aflatoxin. 57 
 58 
Human exposure to contaminated food is highest in countries with high consumption of 59 
susceptible staple crops grown and stored under optimal fungal growth conditions. Aflatoxin 60 
exposure often causes acute outbreaks and sometimes fatal liver toxicity (7). Chronic exposure 61 
can increase the risk of liver cancer (8), in particular through an interaction with the hepatitis B 62 
virus. There is increasing evidence that aflatoxin plays a role in other health effects such as 63 
hepatomegaly (9), immune suppression (10-12) and growth faltering in children (13, 14). 64 
Chronic aflatoxin exposure is evident throughout life, including the critical first 1,000 days 65 
(15).  66 
 67 
With the increasing evidence that aflatoxin can exacerbate the effects of undernutrition, and 68 
contribute to growth faltering, it is likely that aflatoxin exposure has inhibited the expected 69 
growth improvement predicted for nutritional intervention programs. In this review we will 70 
summarise the burden of childhood undernutrition and the current achievement of nutritional 71 
specific interventions for improving child growth, review the evidence for aflatoxin exposure 72 
exacerbating undernutrition and reflect on the necessity for considering aflatoxin exposure in 73 
nutritional intervention programs.  74 
  75 
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Child undernutrition and nutrition specific interventions in the developing world  76 
 77 
Protein energy malnutrition  78 
Protein energy malnutrition (PEM), considered to be the leading form of childhood malnutrition 79 
in developing countries, includes the disorders kwashiorkor, marasmus and marasmus- 80 
kwashiorkor, which are differentiated by the balance between inadequate protein intake and 81 
other energy sources (16). PEM is often a consequence of suboptimal breastfeeding, delayed 82 
and/ or inadequate supplementation of appropriate complementary foods, lack of diet diversity 83 
and infection that can lead to decreased absorption of essential nutrients.  84 
 85 
In 2000, the WHO estimated that 26.7% of children < 5 years of age in developing countries 86 
had PEM (17). There is a lack of recently conducted population based studies that have 87 
investigated the prevalence of the different types of PEM in developing countries. Kwashiorkor, 88 
oedematous malnutrition, has been included within the estimates for the prevalence of, and 89 
deaths attributable to, severe acute malnutrition (SAM) (weight-for-height (WHZ) below -3, 90 
according to WHO standards (18)). In 2011 the global prevalence of SAM in children < 5 years 91 
was 3% (19 million) with higher percentages observed in central Africa (5.6%) and south-92 
central Asia (5.1%) (1).  93 
 94 
A recent systematic review evaluated the effectiveness of inpatient management for SAM using 95 
the WHO protocol, as well as community-based treatments in low- and middle-income settings 96 
(19). The authors found that case fatality rates for inpatient management of SAM, following 97 
the WHO protocol, which involves fluid management and micronutrient supplementation, 98 
ranged from 3.4% to 35%. Only two studies reported nutrition recovery rates, which were 99 
79.7% and 83.3%. For the community-based treatment of SAM that involves the use of ready-100 
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to-use therapeutic food (RUTF), 51% of children were more likely to achieve nutritional 101 
recovery than a standard care group. Although, this systematic review was limited in the 102 
availability of high quality studies, the nutritional recovery rates of the interventions reviewed 103 
were advantageous. The authors have concluded that future studies are warranted to compare 104 
approaches to managing SAM and this includes identifying and tackling other aggravating 105 
determinants of SAM.  106 
 107 
Growth faltering 108 
Stunting (height-for-age Z score (HAZ) < 2), wasting (weight-for-height Z score (WHZ) < 2) 109 
and underweight (weight-for-age Z score (WAZ) < 2) (18) are major indicators of child 110 
undernutrition. Severe undernutrition is considered when Z sores are <3. In 2011, 111 
approximately 165 million (25.7%) children under the age of five years globally had stunted 112 
growth, 52 million (8%) were classified as wasting and 100 million (16%) were underweight 113 
(20). South-central Asia (36% stunted, 15% wasting and 30% underweight) as well as East 114 
(42% stunted) and West Africa (36% stunted and 22% underweight) had the highest prevalence. 115 
Growth faltering in early life is a predisposing risk factor for poor cognitive development, 116 
reduced educational outcomes and economic productivity, as well as reduced survival in 117 
adulthood (1). Micronutrient deficiencies alongside recurring infections are some of the well-118 
recognised causes of child growth faltering in developing countries. There are three 119 
micronutrient deficiencies of public health concern in developing countries; vitamin A, Iron 120 
and zinc deficiency. Interventions (supplementation) targeting these specific micronutrients and 121 
their impact on growth outcomes are summarised in table 1. 122 
 123 
Zinc deficiency  124 
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A recent analysis conducted by Wessells and Brown (21) estimated the global prevalence of 125 
zinc deficiency (ZD) as 17% in 188 countries, using zinc intake obtained from FAO food 126 
balance sheets, with zinc and phytate contents calculated using a nutrient composition database 127 
(table 1). Low-income countries such as those in sub-Saharan Africa and South Asia were most 128 
at risk with a ZD prevalence of over 25% (21). ZD is primarily caused by low intake of animal 129 
products and exacerbated by persistent diarrhoea (22, 23). ZD can negatively impact the 130 
immune system, thereby enhancing susceptibility to infectious diseases such as diarrhoea, 131 
malaria and pneumonia, especially in children (22). It may also aggravate intestinal 132 
permeability and chronic inflammation, both pathways that underlie environmental 133 
enteropathy, which is a sub-clinical condition involving reduced intestinal function that can 134 
affect micronutrient absorption (23). Zinc has a fundamental role in cell division and growth; 135 
thus, it can result in decreased concentrations of circulatory Insulin-like Growth Factor 1 (IGF-136 
1), a possible pathway for slowed child growth in Zinc deficient children (24).  137 
 138 
ZD in developing countries coincides with the high prevalence of stunted growth in children 139 
observed in these countries (1, 21). In fact, assessing the number of children < 5 years old that 140 
have stunted growth has been considered to be a proxy for zinc deficiency (21, 25), although 141 
this is an indirect method of measuring ZD, and consequently is subject to confounding factors. 142 
It would be expected, therefore, that zinc supplementation would have a positive effect on 143 
growth. Four meta-analyses (26-29) have been identified that have investigated the impact of 144 
zinc supplementation on growth indices in childhood (table 1). Three meta-analyses found that 145 
zinc supplementation had a significant positive effect on linear growth (26, 27, 29) and two 146 
found it had a positive effect on weight gain (26, 27). In contrast, Ramakrishnan et al. (28) 147 
found no effect of zinc supplementation on linear growth or weight change but did find a 148 
significant positive effect on change in WHZ score. Although it is apparent from the 149 
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aforementioned evidence that zinc can have a positive impact on growth, it is important to 150 
highlight that its effect is only marginal. 151 
 152 
Iron deficiency  153 
Iron deficiency (ID) is the leading cause of anaemia (haemoglobin < 110g/L) and accounts for 154 
~50% of all cases (30). For this reason anaemia is typically used as a proxy for ID. Stevens et 155 
al. (31) estimated the global prevalence of total and severe anaemia in three population groups 156 
known to be most vulnerable to these conditions; women of child bearing age (15-49 years), 157 
children (6-59 months) and pregnant women. Using representative population based data 158 
collected from 107 countries, it was evident that anaemia is of epidemic proportions worldwide 159 
(table 1). Regional analysis showed Central and West Africa as having the highest prevalence 160 
of anaemia and severe anaemia in children aged < 5 years in 1995 (80% and 9.7%) and 2011 161 
(71% and 4.9%). The high prevalence observed in developing parts of the world is mostly likely 162 
due to diets low in iron rich foods alongside poor absorption and diets high in phytate 163 
compounds that inhibit iron absorption (32). Parasite infections as well as tuberculosis and HIV 164 
are also thought to be risk factors. 165 
 166 
Poor growth and cognitive development during childhood have been suggested as major 167 
consequences of iron deficiency; although, the evidence supporting these suggestions is 168 
inconclusive. For example, several systematic reviews and meta-analyses of randomized 169 
controlled trials (RCTs) have failed to discover a positive effect of iron supplementation on 170 
different growth parameters in children (table 1) (33-36). However, a recent systematic review 171 
and meta-analysis (37), found a small positive effect on growth (HAZ) in children that were 172 
aged between 5 and 12 years. Likewise, systematic reviews have reported that iron 173 
supplementation can have an impact on cognitive development especially in older children (37, 174 
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38) but appears to be ineffectual in young children and infants (35, 36, 38, 39). This evidence 175 
indicates that iron supplementation may have more of an impact on growth performance and 176 
cognitive development during mid-childhood. Of course, this may challenge the view that 177 
interventions targeting growth should occur in the first 1,000 days of life (2, 3), as beyond this 178 
timeframe interventions are considered to be ineffectual. Nevertheless, it is noticed that the 179 
positive effect on growth reported in these studies (37) was only marginal, indicating that iron 180 
supplementation targeting mid childhood may only have limited success as a public health 181 
intervention.  182 
 183 
Vitamin A deficiency 184 
According to a WHO (40) report, vitamin A deficiency (VAD), defined as having serum 185 
(plasma) retinol concentrations less than < 0.70 ȝPROORUKDYLQJDKLVWRU\RIQLJKWEOLQGQHVV in 186 
more severe cases, is considered a major public health problem in developing countries, 187 
specifically in Asia and sub-Saharan Africa. In that report, the global prevalence of VAD 188 
measured between 1995 and 2005 in pregnant women was 15.3% and when stratified according 189 
to WHO regions, Africa and Asia had the highest rates (14.3% and 18.4%). This trend was also 190 
observed in children under 5 years old. Global prevalence was 33.3%, with Africa (41.6%) and 191 
Asia (33.5%) having higher rates than other parts of the world. 192 
 193 
The developing fetus and preschool aged children are considered to be at-risk populations, 194 
owing to the rapid growth and subsequent increased nutritional requirements during these 195 
stages of the life course. In developing countries these additional nutritional requirements are 196 
frequently not met owing to the lack of diet diversity, as well as the affordability of foods high 197 
in vitamin A such as animal products, citrus fruits and dark green vegetables.  198 
 199 
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Over the past decade, some observational studies have found that maternal VAD was associated 200 
with lower birth weight (41, 42). In contrast, according to a recent systematic review and meta-201 
analysis vitamin A supplementation during pregnancy had no positive effect on birth weight 202 
(43). Furthermore, vitamin A supplementation during childhood showed little or no effect on 203 
growth performance in several RCTs (33, 44-47).  204 
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Table 1: Major micronutrient deficiencies of public health concern: prevalence, supplementation and growth outcomes in children 
Micronutrient Prevalence Micronutrient supplementation on 
growth. Evidence from systematic 
reviews and meta-analyses 
Effects on physical growth (95%CI) 
Zinc Wessells and Brown (21) 
Using country specific FAO food balance 
sheets 
All ages (> 6months) 
Global: 17.3 ± 11.1% 
sub-Saharan Africa: 25.6 ± 12.2% 
South Asia: 29.6 ± 3.6% 
Prevalence of inadequate zinc intake was 
correlated with the prevalence of stunting in 
children < 5 years (r = 0.48; p <0.001) 
Brown et al. (26) 
Meta-analysis of RCTs 
Children <12 years or prepubertal 
=LQFVXSSOHPHQWDWLRQZHHNV
  
Zinc supplementation had a positive 
effect on change in height (effect size 
= 0.35; 95% CI: 0.19-0.51) and 
change in weight (effect size = 0.31; 
95% CI: 0.18-0.44). There was no 
significant effect on WHZ. 
  Brown et al. (27) 
Meta-analysis of RCTs 
Infants, pre-schooler and older pre-
pubertal 
Zinc supplementation 2 weeks to 15 
months 
 
Zinc supplementation had a positive 
effect on change in height (effect size 
= 0.17; 95% CI: 0.08-0.26), change in 
weight (effect size = 0.12; 95% CI: 
0.05-0.19) and a small marginal effect 
on change in WHZ score (effect size = 
0.06; 95% CI: 0.00-0.12) compared 
with control groups. 
   
Ramakrishnan et al. (28) 
Meta-analysis of RCTs  
&KLOGUHQ\HDUV 
=LQFVXSSOHPHQWDWLRQZHHNV 
 
Zinc supplementation had no 
significant positive effect on change 
height or weight gain but did have a 
small positive effect on WHZ score 
(effect size = 0.06; 95% CI: 0.01-0.11) 
in comparison with placebo-controlled 
groups. 
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Imdad and Bhutta (29) 
Meta-analysis of RCTs  
Children < 5 years 
Zinc supplementation ZHHNV 
 
Zinc supplementation had a positive 
effect on linear growth (effect size = 
0.19; 95% CI: 0.08-0.30) compared to 
placebo-controlled group. 
 
Iron Stevens et al., (31) 
Iron deficiency anaemia (haemoglobin <110 
g/L) 
Children < 5 years 
Global: 43% (95% CI: 38-47) 
Central and West Africa: 71% (95% CI: 
67-74) 
South Asia: 58% (95% CI: 44-69) 
Ramakrishnan et al. (33) 
Meta-analysis of RCTs 
Children < 18 years 
Iron supplementation ZHHNV 
Iron supplementation had no 
significant effect on height or weight 
compared to a control group. 
  Sachdev et al. (34) 
Meta-analysis of RCTs 
Children < 14 years 
Oral Iron supplementation duration 
2 months to 12 months 
Iron supplementation had no 
significant effect on WAZ, WHZ, 
HAZ, mid upper arm circumference, 
skinfold thickness or head 
circumference compared to control 
groups. 
   
Low et al. (37) 
Meta-analysis of RCTs 
Children 5 to 12 years 
Oral iron supplementation GD\V
per week 
 
Iron supplementation had no 
significant effect on absolute height or 
absolute weight or WHZ score but did 
have a significant but small positive 
effect on HAZ score compared with a 
control group (effect size = 0.09; 95% 
CI: 0.01-0.17). 
   
Pasricha et al. (35) 
Meta-analysis of RCTs  
Children aged 4-23 months 
 
Iron supplementation had no 
significant effect (P > 0.05) on final 
weight, WAZ scores, change in 
13 
 
Daily oral iron supplementation weight, final length, HAZ scores, 
change in length or weight for length z 
score in comparison with the control 
group. 
   
Thompson et al. (36) 
Meta-analysis of RCTs 
Children 2 to 5 years 
Oral iron supplementation GD\V
per week 
 
Iron supplementation had no positive 
effect on final height, final weight, 
change in height and change in weight 
compared to a control group 
 
Vitamin A 
 
WHO (40) (Serum retinol <0.70 µmol/L) 
Children < 5 years 
Global: 33.3% (95% CI: 31.1-35.4) 
Africa: 44.4% (95% CI: 41.3-47.5) 
South East Asia: 49.9% (95% CI: 45.1-
54.8) 
 
Ramakrishnan et al. (33) 
Meta-analysis of RCTs 
Children < 18 years 
Vitamin A supplementation 
weeks 
 
Vitamin A supplementation had no 
positive effect on absolute height 
change or weight change 
14 
 
It is clear from the evidence above that supplementation interventions targeting the main 205 
micronutrients of public health concern in developing countries are not entirely effective in 206 
improving child growth. Vitamin A supplementation markedly has no impact on child growth, 207 
whereas zinc and iron supplementation seem to have peripheral effects. This suggests that there 208 
are other underlying determinants of child growth faltering that need to be addressed. 209 
 210 
Aflatoxin related undernutrition issues in the developing world 211 
Aflatoxin exposure and its relationship with growth faltering. 212 
The development and application of the AF-alb biomarker has enabled a number of 213 
epidemiology studies examining human health effects of aflatoxin exposure (48). This 214 
biomarker, which is usually measured by an ELISA method (49) has shown a good correlation 215 
with aflatoxin intake in adults through a groundnut based diet in The Gambia (50), as well as 216 
in children through a maize-based weaning diet in Tanzania (51). Compared to other available 217 
short term (for previous 1-2 days exposure) biomarkers such as the aflatoxin DNA adduct, 218 
AFM1 and aflatoxin metabolites in urine, this biomarker reflects the previous 2-3 months 219 
exposure at the individual level, and is therefore more appropriate for assessing chronic 220 
exposure related health outcomes.  221 
 222 
There is mounting evidence that aflatoxin exposure occurs from gestation onwards throughout 223 
life (15). Exposure occurs in utero through the transfer of aflatoxins from the mother to the 224 
foetus via the placenta. Several studies have investigated this route of exposure and have found 225 
detectable levels of aflatoxin or AF-alb in cord blood samples (52-56). Only a few studies have 226 
examined the impact of exposure in utero on birth weight (57-59). All have reported a 227 
significant inverse relationship with higher exposure in utero corresponding to lower weight at 228 
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birth. A study by de Vries et al (57) conducted in rural Kenya, examined aflatoxin levels in 229 
maternal and cord blood samples. Aflatoxin was detected in over half of the maternal samples 230 
and 37% of the cord blood samples. Females born to aflatoxin positive mothers had a mean 231 
birth weight that was 225g lower than those born to mothers free from aflatoxin exposure. 232 
Similar results were observed in a study conducted in the Middle East by Abdulrazzaq et al., 233 
(58), where high aflatoxin levels in maternal and cord blood samples were significantly related 234 
to lower birth weights (r = -0.654, P = 0.0001 and r = -0.565, P = 0.001, respectively). More 235 
recently, a cross-sectional study of 785 pregnant Ghanaian women, after adjusting for socio-236 
demographic variables and other factors, found increased odds of delivering a baby with a low 237 
birth weight in the highest quartile (59). The highest quartile represented the highest levels of 238 
aflatoxin exposure measured in blood during pregnancy (OR, 2.09; 95% CI: 1.19±3.68).  239 
 240 
Aflatoxin exposure in utero may also play a role in stunted growth in early childhood (up 24 241 
months). Only one study to date has explored this temporal relationship (56), and found that 242 
higher levels of AF-alb in maternal blood were significantly associated with lower weight (P = 243 
0.012) and height (P = 0.044) gain, after adjusting for potential confounding factors. 244 
Furthermore, the authors predicted that a reduction in maternal AF-alb level from 110 pg/mg 245 
to 10 pg/mg would lead to a 2 cm increase in height and a 0.8 kg increase in weight within the 246 
first 24 months of life. 247 
 248 
Usually studies that have examined exposure in utero by measuring maternal blood only 249 
obtained measurements at one point in time. A recent study conducted by Castelino et al., (60) 250 
explored the effect of season and gestation stage on aflatoxin exposure in pregnant women from 251 
Gambia. Results showed that mean AF-alb levels were higher during the dry season than the 252 
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rainy season. AF-alb levels increased marginally from early to later gestation during the dry 253 
season (41.8 vs 34.5 pg/mg; P < 0.05). Although early pregnancy has been considered a period 254 
when the foetus is most vulnerable, later pregnancy marks the fast growth period of the foetus, 255 
which may exert a profound adverse impact on growth. Further research is warranted to 256 
determine the longer term health effects of aflatoxin exposure during both early and late 257 
pregnancy. 258 
 259 
Weaning is the transition from breast milk to solid food, and typically commences between 3 260 
and 6 months. It is often a period in developing countries when children are most susceptible 261 
to PEM, specifically, kwashiorkor. Because weaning foods such as maize are prone to aflatoxin 262 
contamination, there may also be high aflatoxin exposure during the weaning period. This was 263 
evident in a study conducted by Gong et al., (61) in Benin and Togo, as children that were fully 264 
weaned had approximately 2-fold higher mean AF-alb levels than children who were still 265 
partially breastfed. Although breastfeeding is a period of lower aflatoxin exposure, there is still 266 
some exposure from breast milk, with aflatoxin M1 having been found in breast milk samples 267 
in many studies (62). Nevertheless, AFM1, which is the hydroxylated metabolite of aflatoxin 268 
that is found in milk, is less toxic than AFB1 that is found in food; therefore extending the 269 
breastfeeding period may help reduce the negative health impacts, such as growth faltering, that 270 
are associated with aflatoxin exposure. 271 
 272 
The impact of aflatoxin exposure on growth is considered the most prominent during the first 273 
two years after birth. One of the first studies examining the association between aflatoxin 274 
exposure and child growth performance was a cross-sectional study of 480 children from Benin 275 
and Togo aged between 9-months and 5 years (13). Prevalence of aflatoxin was high in this 276 
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sample with 99% of the children having detectable levels and a reported geometric mean of 277 
32.8 pg/mg. Undernutrition was also evident as 33%, 6 % and 29% of the children were 278 
classified as having stunted growth (HAZ <-2), wasting (WHZ <-2) and being underweight 279 
(WAZ <-2); respectively. Significant negative correlations between AF-alb and each of the 280 
growth parameters were observed (P = 0.001 for stunting; P = 0.047 for wasting and P = 0.005 281 
for underweight). Another cross-sectional study by Turner et al., (10) found that AF-alb levels 282 
were weakly associated with wasting (P = 0.034) but not with stunting or underweight. 283 
 284 
These earlier studies were the first in determining the association of aflatoxin dietary exposure 285 
with growth impairment in human subjects, and generated hypotheses for further investigations. 286 
Cross-sectional studies are the best way to measure prevalence (63); however, they do have 287 
limitations, as they cannot be used to establish the temporal sequence of the relationship 288 
observed. A subsequent study using a longitudinal design, examined the effects of aflatoxin 289 
exposure on growth in a cohort of 200 children from Benin (16-37 months) followed up over 290 
8-months (14). High prevalence of aflatoxin exposure was found across the cohort with almost 291 
all samples being positive for aflatoxin at each time point and with mean AF-alb levels of 37.4 292 
pg/mg (February), 38.7 pg/mg (June) and 86.8 pg/mg (October). Results showed that both AF-293 
alb levels measured in February and the mean AF-alb level from the three time points, were 294 
inversely correlated with HAZ and WHZ growth parameters that were measured at the end of 295 
the study. This relationship remained after adjusting for potential confounding factors such age, 296 
sex, height, weaning status, SES and geographical location, although only for the HAZ growth 297 
parameter (P < 0.001). Furthermore, there was a difference in height of 1.7 cm between the 298 
highest and lowest AF-alb quartile over the 8 month period. This study has helped to show the 299 
temporal relationship between aflatoxin exposure and impaired child growth. Although 300 
additional longitudinal studies conducted in different geographical locations and populations 301 
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will strengthen the evidence on the likelihood of this effect being cause and effect. Furthermore, 302 
plausible mechanisms that link aflatoxin exposure with impaired child growth should be 303 
investigated. 304 
 305 
Aflatoxin exposure and protein-energy malnutrition  306 
It has been proposed that the development of kwashiorkor may be partly attributable to aflatoxin 307 
exposure, although the evidence is circumstantial. Both aflatoxin exposure and kwashiorkor are 308 
prevalent in hot and humid tropical countries where maize and rice are staples, both affect 309 
children in early life and both are associated with impaired child growth (15, 64). In addition, 310 
the clinical and metabolic manifestations of kwashiorkor are somewhat similar to those of 311 
aflatoxin exposure, such as fatty liver and immunosuppression (65). 312 
 313 
As shown in table 2, the association between the exposure to aflatoxin and kwashiorkor has 314 
EHHQLQYHVWLJDWHGLQDSOHWKRUDRIVWXGLHVVLQFHWKH¶V65-78). The typical study designs 315 
employed by the majority of these studies were case-control or cross-sectional, and involved 316 
measuring the prevalence and concentration of aflatoxin in blood and urine samples. In most 317 
studies it was found that aflatoxin was detected more frequently or concentrations were higher 318 
in blood samples of children with kwashiorkor in comparison with children with marasmus, 319 
and healthy children (65, 68, 69, 76-78). Furthermore, aflatoxin was detected more often in 320 
liver specimens from children who had died from kwashiorkor compared to other diseases and 321 
other protein malnutrition disorders (66). 322 
 323 
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Although evidence suggests that aflatoxin exposure may be related to kwashiorkor prevalence, 324 
a causal relationship has not been established. Furthermore, most of the studies did not measure 325 
AF-alb levels in serum of exposed children, which has been shown to be a more reliable 326 
biomarker. A fundamental step in unravelling any link between aflatoxin and kwashiorkor is to 327 
understand the possibility that the metabolic manifestations of kwashiorkor affect the way that 328 
aflatoxins are metabolised and excreted from the body, or vice versa. Future studies, 329 
undertaking a longitudinal design are required to determine if aflatoxin exposure plays an 330 
aetiological role in the causation of kwashiorkor. 331 
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Table 2. The relationship between protein energy malnutrition and aflatoxin exposure 
Study Country/ study population  Aflatoxin Exposure 
  Blood ± detection (%) and 
mean concentration  
Urine ± detection (%) and 
mean concentration  
Other ± detection (%) and 
mean concentration  
Hendrickse et 
al. (65) 
 
 
Country: Sudan 
252 children 
K (n = 44) 
MK (n = 32) 
M (n = 70) 
AM controls (n = 106) 
177 samples (total aflatoxin 
pg/ml). 
K (36.4%) (GM: 706)  
MK (21.9%) (GM: 412) 
M (19.3%) (GM: 211) 
AM controls (15.9%) (GM: 77) 
The difference between the 
groups approached significance 
(P = 0.05). 
Kwashiorkor group mean 
aflatoxin concentration was 
significantly higher than the 
control group (P = 0.01). 
 
250 samples (total aflatoxin 
pg/ml). 
K (36.4%) (GM: 706)  
MK (21.9%) (GM: 412) 
M (19.3%) (GM: 211) 
AM controls (15.9%) (77) 
No significant differences 
between the groups identified. 
 
Lamplugh and 
Hendrickse, 
(66) 
Country: Nigeria and South 
Africa 
8 children (aged between 9 
months and 24 months) 
K (n = 3) 
MK (n = 3) 
M (n = 1) 
Control (n = 1) 
 
  8 autopsy liver specimens. 
K (all three of the liver samples 
contained AFB1: 2000, 4900 
and 1400 pg/g). 
MK (1 liver sample had no 
aflatoxins; one contained a 
small quantity of aflatoxin M1 
(15 pg/g) and in the third 
sample aflatoxicol was found 
(8500 pg/g). 
M (no aflatoxins found) 
Control (no aflatoxin found) 
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Apeagyei et al, 
(67) 
Country: Ghana 
22 children (aged between 5 
months and 48 months) 
K (n = 22) 
 
  22 autopsy liver specimens 
Aflatoxin B1 was detected in 20 
of the samples (90.9%). The 
remaining 2 samples contained 
aflatoxicol (9.1%). 
Coulter et al., 
(68) 
Country: Sudan 
584 children 
K (n = 141) 
MK(n = 152) 
M (n = 152) 
AM controls (n = 180) 
457 samples (total aflatoxin 
pg/ml) 
K (37.7%) (GM:154) 
MK (28.6%) (GM: 82) 
M (26.3%) (GM: 77) 
AM controls (21.3%) (GM: 81) 
Difference between the number 
of positive samples found in 
each group was significant (P 
<0.05). 
No differences between the 
groups in concentrations of 
aflatoxin identified. 
 
463 samples (total aflatoxin 
pg/ml) 
K (27.2%) (GM: 308) 
MK(39.0%) (GM: 490) 
M (26.1%) (GM: 438) 
AM controls (28.4%) (GM:258) 
No significant difference 
between the numbers of positive 
samples found in each group.  
No significant differences 
between the groups in 
concentrations of aflatoxin 
identified. 
 
deVries et al., 
(69) 
Country: Kenya 
41 children 
K (n = 14) 
MK (n = 6) 
M (n = 11) 
Controls (n = 10) 
 
39 samples (total aflatoxin 
(pg/ml) 
K (64%) (mean: 6666) 
MK (50%) (mean: 386) 
M (36%) (mean: 3412) 
Controls (30%) (mean: 759) 
 
36 samples (total aflatoxin 
pg/ml) 
K (42%) (mean: 324) 
MK (60%) (mean: 1294) 
M (45%) (mean: 261) 
Controls (75%) (mean: 759) 
No differences in detection 
rates.  
 
 
de Vries et al., 
(70) 
Country: Kenya 
13 children 
K (n = 5) 
 K (4 out of 5 children excreted 
aflatoxin via urine).  
K (all 5 of the children excreted 
aflatoxin in their stools). 
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MK (n = 7) 
Underweight (n = 1) 
 
MK (5 out of 7 children 
excreted aflatoxin via urine).  
7KHXQGHUZHLJKWFKLOG¶VXULQH
samples tested negative for 
aflatoxin. 
Total aflatoxin excreted (urine 
and stools) ranged from 0.08 
ug/kg to 4 ug/kg body weight).  
MK (3 out of 7 children 
excreted aflatoxin in their 
stools).  
Total aflatoxin excreted (urine 
and stools) ranged from nil to 
1.5 ug/kg body weight).  
7KHXQGHUZHLJKWFKLOG¶VVWRROV
tested negative for aflatoxin. 
 
Househam and 
Hundt (71) 
 
Country: South Africa 
320 children (mean age of 
38 months) 
K (n = 47) 
M (n = 17) 
Controls (n = 256) 
 
  
448 urine samples 
Aflatoxin B1, B2, G1, G2 and 
aflatoxicol were not detected in 
any of the samples. 
 
Ramjee et al., 
(72) 
Country: South Africa 
109 children aged between 
6 months and 2 years 
K (n = 45) 
M (n = 13 
Underweight (n = 16) 
AM controls (n = 35) 
 
109 samples 
K (56%) 
M (31%) 
Underweight (56%) 
AM controls (49%) 
No differences among the 
groups in the number of 
aflatoxin positive results. 
50 samples 
K (16%) 
M (10%) 
Underweight (no samples 
tested) 
Age matched controls (25%) 
No differences among the 
groups in the number of 
aflatoxin positive results. The 
serum/ urine ratio was 
significantly higher in the 
kwashiorkor group than in the 
other groups (P = 0.001). 
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Adhikari et al., 
(73) 
Country: South Africa 
36 children aged between 6 
months and 2 years 
K (n=36) 
36 samples 
Aflatoxin was detected in 21 
samples (58%) 
  
 
Oyelami et al., 
(74) 
 
Country: Nigeria 
40 children (aged between 4 
and 168 months) 
20 children who died from 
kwashiorkor  
20 children who died of 
other diseases  
 
   
40 lung specimens 
K (90%) 
Other diseases (65%) 
No significant differences 
among the groups in the number 
of aflatoxin positive results. 
 
Oyelami et al., 
(75) 
Country: Nigeria 
45 children  
24 children who died from 
kwashiorkor (aged between 
6 months and 72 months) 
21 children who died of 
other diseases (aged 
between 4 months and 168 
months) 
  45 kidney specimens (total 
aflatoxin pg/g) 
K (58%) (mean: 3851) 
Other diseases (62%) (mean: 
1271) 
No significant differences 
among the groups in the number 
of aflatoxin positive results. 
No differences among the 
groups in mean concentrations 
of total aflatoxins. 
 
Hatem et al., 
(76) 
 
Country: Egypt 
70 children (aged between 6 
and 24 months) 
K (n = 30) 
M (n = 30) 
AM controls (n = 10) 
 
 
30 samples (total aflatoxin 
ng/ml) 
K (80%) (mean: 70.58) 
Ma (46.7%) (mean: 25.21) 
AM controls (0) 
Aflatoxins were detected more 
frequently in blood samples of 
 
30 samples (total aflatoxin 
ng/100ml) 
K (80%) (mean:  
M (46.7%) 
AM controls (0) 
Aflatoxins were detected more 
frequently in urine samples of 
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the kwashiorkor group than the 
marasmus group (P = 0.007).  
Mean serum levels of total 
aflatoxin were significantly 
higher in the kwashiorkor group 
relative to the marasmus group 
(P <0.001). 
the kwashiorkor group than the 
marasmus group (P = 0.007). 
Mean levels of total aflatoxin 
excreted in urine were 
significantly higher in the 
kwashiorkor group relative to 
the marasmus group (P = 
0.052). 
 
 
Tchana et al., 
(77) 
 
Country: Cameroon 
78 children (aged between 
13 months and 12 years) 
K (n = 31) 
MK (n=11) 
AM controls (n = 36) 
  
42 samples (aflatoxin B1) 
K (35.5%) 
MK (45.5%) 
AM controls (11.1%) 
Detection levels of AFB1 
excreted in urine were 
significantly higher in the 
kwashiorkor and marasmus 
kwashiorkor groups relative to 
the control group (P <0.05). 
 
 
Onyemelukwe 
et al. (78) 
Country: Nigeria 
111 children (aged between 
7 months and 60 months) 
K (n = 36) 
MK (n = 29) 
M (n = 13) 
AM controls (n = 33) 
111 samples (total aflatoxin 
ug/L) 
K (88.9%) (median: 165.6) 
MK (93.1%) (median: 228.4) 
M (76.9%) (median: 234.3) 
AM controls (63.6%) (median: 
20.7) 
Median serum levels of total 
aflatoxin were significantly 
higher in each protein energy 
malnutrition group relative to 
55 samples (total aflatoxin 
ug/L) 
K (84.6%) (median: 79) 
M (60%) (median: 43.8) 
Ma (81.8%) (median: 14.4) 
AM controls (90.9%) (median: 
42.6) 
No differences among the 
groups in the number of 
aflatoxin positive results. 
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the control group (kwashiorkor 
vs. control P <0.001, marasmic 
kwashiorkor vs. control P 
<0.001, marasmus vs. control P 
= 0.031). There were no 
significant differences between 
the protein malnutrition groups. 
Median total aflatoxin levels in 
urine samples were significantly 
higher in the kwashiorkor group 
relative to the marasmus group 
(P = 0.011). No other 
significant differences were 
identified between the groups. 
Abbreviation: AM, age-matched; GM, geometric mean; K, kwashiorkor; M, marasmus; MK, Marasmic kwashiorkor 
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Aflatoxin exposure and micronutrient deficiencies 332 
It has been hypothesized that aflatoxin exposure mediates intestinal damage resulting in 333 
reduced nutrient absorption and increased intestinal permeability resulting in faltered growth 334 
(79, 80). It is, therefore, possible that aflatoxin exposure exacerbates micronutrient deficiencies 335 
and by reducing aflatoxin exposure the incidence of micronutrient deficiencies may be reduced 336 
correspondingly. Previous research has established the relationship between aflatoxin exposure 337 
and the effect on these micronutrients in feeding experiments in animal studies as reviewed by 338 
Williams et al., (81). Increasing levels of aflatoxin in feed were significantly related to 339 
decreasing concentrations of vitamin A in poultry (82); vitamin D concentrations in chickens 340 
(83); vitamin A and E in swine (84) as well as zinc in piglets (85). 341 
 342 
Owing to the species difference, it is difficult to directly apply these findings to humans. Only 343 
a few studies have been identified that have examined the relationship between micronutrient 344 
concentrations and aflatoxin exposure in humans. Two of these studies were conducted in 345 
children (10, 14). As part of their investigation into the effect of aflatoxin exposure on immune 346 
function in Gambian children aged between 6 and 9 years Turner et al. (10) investigated the 347 
correlation between vitamins A (a- and b-carotene and lycopene) and C with AF-alb levels. 348 
Vitamin C was the only micronutrient that demonstrated an inverse relationship with AF-alb (P 349 
= 0.01). A study conducted by Gong et al. (14) that examined the relationship between aflatoxin 350 
exposure during the post weaning period and growth faltering, measured vitamin A and zinc 351 
levels to assess if they were potential confounding factors. No significant correlations between 352 
vitamin A and zinc with AF-alb levels were observed. A more recent cross-sectional study (86) 353 
of 147 Ghanaian adults found a significant negative correlation between AF-alb levels and 354 
vitamin A concentrations in plasma samples (-0.20; p<0.05). Participants with high AF-alb 355 
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levels (>0.80 pmol/mg albumin) had a 2.6-fold greater risk of having lower vitamin A levels 356 
after adjusting for potential confounding factors (odds ratio = 2.61; CI = 1.03- 6.58; P = 0.04). 357 
Tang et al., (87) found similar results in another sample of 507 Ghanaian adults. A correlation 358 
analysis revealed significant negative correlations between AFB1-albumin adducts and vitamin 359 
A (r = -0.110; p = 0.013) and vitamin E (r = -0.149; p <0.001). 360 
 361 
It is very difficult to draw specific conclusions based on the above evidence. Firstly, only a 362 
small number of studies have been identified that have examined the relationship between 363 
aflatoxin exposure and micronutrient deficiency in human subjects. Secondly, two studies 364 
found no associations between vitamin A and AF-alb levels, whereas two studies did, indicating 365 
that this relationship is not consistent across studies. Furthermore, the temporal relationship has 366 
not yet been investigated as the above studies were cross-sectional; although Gong et al. (14) 367 
was a longitudinal study, the micronutrients measured were only considered as potential 368 
confounding factors for the relationship between aflatoxin exposure and impaired child growth, 369 
and further explorations of these variables were not carried out. It is, consequently, still 370 
unknown whether aflatoxin exposure exacerbates micronutrient deficiencies and if this 371 
contributes to impaired child growth, which previous researchers have advocated (80). Future 372 
studies opting for a longitudinal or experimental (RCT) design are warranted to help establish 373 
whether a temporal relationship exists.  374 
 375 
3RVVLEOHPHFKDQLVPVIRUDIODWR[LQ¶VHIIHFWVRQJURZWK 376 
It has been hypothesized that aflatoxin may affect child growth through one or more of three 377 
mechanisms; 1) by contributing to enteropathy, 2) immune suppression and 3) modulating the 378 
insulin-like growth factor (IGF) pathway through liver toxicity (79, 80). Enteropathy is a 379 
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frequent condition observed in babies in Africa, and may be partly attributable to aflatoxin 380 
related toxic damage to the intestine HSLWKHOLXPZKLFKOHDGVWRIXUWKHU³OHDN´RIQXWULHQWVLH381 
aflatoxin exacerbates the reduction of nutrient uptake in an environment where undernutrition 382 
is already rife. The immune suppression effect of aflatoxin, for which there is a lot of evidence 383 
in animal species (88), and increasing evidence in humans (10-12), could enhance susceptibility 384 
to infections such as those causing diarrhoea, which would reduce nutrient uptake. Liver 385 
toxicity due to chronic aflatoxin exposure may damage the production of Insulin like Growth 386 
Factor pathway proteins (IGFs) in the liver, leading to reduced IGFs in circulation and an 387 
adverse impact on child growth. A recent in vitro study using human liver cells demonstrated 388 
that aflatoxin down-regulated IGFs genes and protein levels in a dose-dependent manner (89). 389 
In agreement with this result, both IGF1 and IGFBP3 levels were found to be inversely 390 
correlated with AF-alb biomarker in Kenyan schoolchildren. Although the effect of aflatoxin 391 
on IGFs only explained about 16% of total effect of aflatoxin on child growth, given the 392 
complex causes of child stunting, the data provides preliminary evidence that aflatoxin-induced 393 
changes in IGFs could contribute to growth impairment where aflatoxin exposure is high (89).  394 
 395 
Aflatoxin co-exposure with other mycotoxins on child undernutrition 396 
Many countries in sub-Saharan Africa have a largely maize-based diet for both weaning food 397 
and family food. It has been noted that groundnuts, although often having higher incidence and 398 
levels of aflatoxin contamination than maize, rarely cause aflatoxicosis. Major aflatoxicosis 399 
often occurs in populations with high maize consumption. This is partly because maize is a 400 
major component of the diet and is consumed in much larger amounts than groundnuts. Another 401 
possibility is that another mycotoxin, fumonisin, often co-occurs with aflatoxin in maize in 402 
these regions (90-92) and it is hypothesized that the co-exposure may greatly enhance aflatoxin 403
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toxicity, both acute (aflatoxicosis), and chronic such as the childhood hepatomegaly reported 404 
in Kenya (9).  405 
Weaning food was found to be frequently co-contaminated with aflatoxin and fumonisin in 406 
Tanzania, and fumonisin exposure by dietary assessment has been reported to be associated 407 
with child stunting and linear growth in Tanzania (93). One hundred and sixty-six children 408 
(aged 6-14 months) from representative regions in Tanzania were studied longitudinally over 409 
one year to examine exposure to both mycotoxins and its impact on child growth. AF-alb levels 410 
tripled during the first 6 months, and further doubled during the second 6 months, with mean 411 
levels of 4.7, 12.9 and 23.5 pg/mg, respectively. Fumonisin exposure measured using urinary 412 
FB1 biomarker was exceedingly high at both maize harvest seasons but with a lower level 413 
observed at 6 months after harvest, reflecting a field mycotoxin contamination pattern (92). 414 
Urinary FB1 at recruitment were negatively associated with HAZ at both 6 months and 12 415 
months from recruitment. Mean levels of urinary FB1 had an inverse association with HAZ at 416 
12 months from recruitment and length velocity. The negative association between AF-alb and 417 
HAZ was not significant, possibly owing to study power limitation. These data show that 418 
fumonisin may contribute to child growth impairment and highlight the potential role of co-419 
contamination with aflatoxin and fumonisin. More recently, Srey et al. (94) reported exposure 420 
to dietary deoxynivalenol (DON), another mycotoxin with known growth inhibition in animals, 421 
also occurs in these children, in agreement with food based exposure analysis in Tanzania (95).  422 
This suggests that the children are frequently exposed to the three mycotoxins, all of which may 423 
have an impact on growth faltering. 424 
 425 
An increasing number of recent studies have reported multi-mycotoxin exposure in different 426 
populations including some African groups (96-98). The methodology applied in these studies 427 
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typically involves simultaneous measurement of multiple mycotoxins using advanced LC-428 
MS/MS technique, and this offers great advantages as it gives useful data on multi-mycotoxin 429 
exposure in a population. At present validation of the approach when applied to health outcomes 430 
is in its infancy.  It was evident from these studies that firstly, multiple mycotoxins co-exist in 431 
staple foods such as maize and their by-products (96) and secondly, human populations in 432 
Africa are co-exposed to proportionally high levels of multi-mycotoxins (97, 98). Ediage et al. 433 
(97) cross-sectional study found no association between stunting, wasting or underweight in 434 
children aged under five, although multiple mycotoxins were found in urine samples. Whilst 435 
the multi-mycotoxin measurements require further validation, these studies provide a preview 436 
of the co-exposure issue and with time more will be revealed, adding further complexity to the 437 
health risk studies. How to assess the health outcomes associated with multiple toxins will thus 438 
be a critical challenge ahead and this will lead to a new era of multiple toxins exposure 439 
assessment methodology development.   440 
 441 
Conclusions 442 
Aflatoxin exposure is highly prevalent in developing countries; often this co-exists with 443 
malnutrition, enteropathy, and infectious disease in young children. The fact that over 90% of 444 
samples from young children from West Africa had detectable AF-alb, in contrast to less than 445 
1% in the developed world clearly demonstrates a huge public health burden associated with 446 
aflatoxin in sub-Saharan Africa. The greatest challenge ahead is not only to understand how 447 
these problems may interactively impact on child stunting, but more importantly to explore the 448 
most effective intervention method for child undernutrition, and eventually to reduce child 449 
mortality. Many supplementation trials targeting the major micronutrient deficiencies aimed at 450 
improving child growth have failed to produce a significant positive effect. We believe that the 451 
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high levels of aflatoxin exposure in these populations are likely to be exacerbating the problems 452 
posed by child undernutrition and that future nutrition interventions should take aflatoxin 453 
exposure into account. The most effective outcomes are likely to be produced by an attack on 454 
two fronts- reduction of aflatoxin exposure and improvement in nutritional status. 455 
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